PRINCETON, N.J.--(BUSINESS WIRE)--Derma Sciences, Inc. (Nasdaq:DSCI), a medical device and pharmaceutical company focused on advanced wound care, today announced a $7.0 million strategic investment in ...

Medihoney leading change in how company makes money in the health care spaceDerma Sciences, Inc. has begun to see the fruit from its strategic labors to shift its focus from everyday health care ...

Derma Sciences is a global manufacturer and marketer of advanced wound care products. Its key product, MEDIHONEY, is sold throughout the world by Derma Sciences and Comvita New Zealand -- the licensor ...

TRENTON, N.J. (AP)-- Amid growing concern over drug-resistant superbugs and nonhealing wounds that endanger diabetes patients, nature's original antibiotic -- honey -- is making a comeback. More than ...

PRINCETON, N.J.--(BUSINESS WIRE)--Derma Sciences, Inc. (Nasdaq: DSCI), a tissue regeneration company focused on advanced wound and burn care, announces the launch of new, MEDIHONEY ® Hydrogel Sheet ...

PRINCETON, N.J.--(BUSINESS WIRE)-- Derma Sciences, Inc. (Nasdaq: DSCI) , a medical device and pharmaceutical company focused on advanced wound care, is showcasing its MEDIHONEY® line of advanced wound ...

Derma Sciences is a global manufacturer and marketer of advanced wound-care products. Its key product, MEDIHONEY, is sold throughout the world by Derma Sciences and Comvita New Zealand -- the licensor ...

Amid growing concern over drug-resistant superbugs and nonhealing wounds that endanger diabetes patients, nature's original antibiotic — honey — is making a comeback. More than 4,000 years after ...

TRENTON, N.J. — Amid growing concern over drug-resistant superbugs and nonhealing wounds that endanger diabetes patients, nature’s original antibiotic — honey — is making a comeback. More than 4,000 ...

* Says codes awarded on Aug 19, by centers for Medicare and Medicaid services * Says looking forward to launch of two more Medihoney products into Medicare market by end of year Source text for Eikon: ...